Gilead Sciences to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, February 6, 2018
January 23 2018 - 4:01PM
Business Wire
Conference Call and Webcast to
Follow
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its
fourth quarter and full year 2017 financial results will be
released on Tuesday, February 6, after the market closes. At 4:30
p.m. Eastern Time, Gilead’s management will host a conference call
to discuss the company’s financial results for the fourth quarter
and full year 2017 as well as provide a general business update and
financial guidance for 2018.
The live webcast of the call can be accessed at the company’s
Investors page at www.gilead.com/investors. Please connect to the
company’s website at least 15 minutes prior to the start of the
call to ensure adequate time for any software download that may be
required to listen to the webcast. Alternatively, please call
1-877-359-9508 (U.S.) or 1-224-357-2393 (international) and dial
the conference ID 6478317 to access the call. Telephone replay will
be available approximately two hours after the call through 11:59
p.m. Eastern Time, February 8, 2018. To access the replay, please
call 1-855-859-2056 (U.S.) or 1-404-537-3406 (international) and
dial the conference ID 6478317. The webcast will be archived on
www.gilead.com for one year.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180123006407/en/
Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024